UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM

Computer methods and programs in biomedicine, 2005-09, Vol.79 (3), p.241-257

2005

Volltextzugriff (PDF)

Full random effects models (FREM): A practical usage guide

CPT: pharmacometrics and systems pharmacology, 2024-08, Vol.13 (8), p.1297-1308

2024

Volltextzugriff (PDF)

Using forest plots to interpret covariate effects in pharmacometric models

CPT: pharmacometrics and systems pharmacology, 2024-05, Vol.13 (5), p.743-758

2024

Volltextzugriff (PDF)

Efficient and relevant stepwise covariate model building for pharmacometrics

CPT: pharmacometrics and systems pharmacology, 2022-09, Vol.11 (9), p.1210-1222

2022

Volltextzugriff (PDF)

Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study

Cancer chemotherapy and pharmacology, 2022-05, Vol.89 (5), p.655-669

2022

Volltextzugriff (PDF)

A quantitative approach to the choice of number of samples for percentile estimation in bootstrap and visual predictive check analyses

CPT: pharmacometrics and systems pharmacology, 2022-06, Vol.11 (6), p.673-686

2022

Volltextzugriff (PDF)

Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques

CPT: pharmacometrics and systems pharmacology, 2021-04, Vol.10 (4), p.330-339

2021

Volltextzugriff (PDF)

Power, selection bias and predictive performance of the population pharmacokinetic covariate model

Journal of pharmacokinetics and pharmacodynamics, 2004-04, Vol.31 (2), p.109-134

2004

Volltextzugriff (PDF)

An introduction to the full random effects model

CPT: pharmacometrics and systems pharmacology, 2022-02, Vol.11 (2), p.149-160

2022

Volltextzugriff (PDF)

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children

Pharmaceutics, 2021-02, Vol.13 (2), p.204

2021

Volltextzugriff (PDF)

PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow

The AAPS journal, 2018-05, Vol.20 (3), p.52-52, Article 52

2018

Volltextzugriff (PDF)

A Fast Method for Testing Covariates in Population PK/PD Models

The AAPS journal, 2011-09, Vol.13 (3), p.464, Article 464

2011

Volltextzugriff (PDF)

Properties of the full random‐effect modeling approach with missing covariate data

Statistics in medicine, 2024-02, Vol.43 (5), p.935-952

2024

Volltextzugriff (PDF)

The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models

Journal of pharmacokinetics and pharmacodynamics, 2007-08, Vol.34 (4), p.485-517

2007

Volltextzugriff (PDF)

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK2 receptors, in infants with colic

British journal of clinical pharmacology, 2024-09

2024

Volltextzugriff (PDF)

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK 2 receptors, in infants with colic

British journal of clinical pharmacology, 2024-09

2024

Volltextzugriff (PDF)

Automated covariate model building within NONMEM

Pharmaceutical research, 1998-09, Vol.15 (9), p.1463-1468

1998

Volltextzugriff (PDF)

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients

Clinical pharmacology and therapeutics, 2019-02, Vol.105 (2), p.486-495

2019

Volltextzugriff (PDF)

Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming

Computer methods and programs in biomedicine, 2004-08, Vol.75 (2), p.85-94

2004

Volltextzugriff (PDF)

An integrated model for the analysis of pharmacokinetic data from microdialysis experiments

Pharmaceutical research, 2004-09, Vol.21 (9), p.1698-1707

2004

Volltextzugriff (PDF)

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

British journal of clinical pharmacology, 2016-04, Vol.81 (4), p.688-699

2016

Volltextzugriff (PDF)

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia

Clinical pharmacokinetics, 2017-04, Vol.56 (4), p.421-433

2017

Volltextzugriff (PDF)

Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic–pituitary–gonadal axis following treatment with GnRH analogues

British journal of clinical pharmacology, 2007-06, Vol.63 (6), p.648-664

2007

Volltextzugriff (PDF)

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

BMC medical informatics and decision making, 2015-02, Vol.15 (1), p.7-7, Article 7

2015

Volltextzugriff (PDF)

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data

CNS drugs, 2017-04, Vol.31 (4), p.273-288

2017

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(117)
Schwedisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM

Full random effects models (FREM): A practical usage guide

Using forest plots to interpret covariate effects in pharmacometric models

Efficient and relevant stepwise covariate model building for pharmacometrics

Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study

A quantitative approach to the choice of number of samples for percentile estimation in bootstrap and visual predictive check analyses

Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques

Power, selection bias and predictive performance of the population pharmacokinetic covariate model

An introduction to the full random effects model

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children

PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow

A Fast Method for Testing Covariates in Population PK/PD Models

Properties of the full random‐effect modeling approach with missing covariate data

The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK2 receptors, in infants with colic

Population pharmacokinetic and dose-response models of nepadutant, a selective antagonist of the NK 2 receptors, in infants with colic

Automated covariate model building within NONMEM

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients

Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming

An integrated model for the analysis of pharmacokinetic data from microdialysis experiments

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia

Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic–pituitary–gonadal axis following treatment with GnRH analogues

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data

Suchergebnisse filtern